A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.

NCT01991184 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphocytic Leukemia, Chronic, Diffuse Large B-Cell Lymphoma

Interventions

DRUG: GDC-0853

Sponsor

Genentech, Inc.